BioHealx

About Signum Surgical

Signum Surgical is a private, commercial-stage medical device company pioneering a novel, minimally invasive treatment for anal fistula. Its lead product, the BioHealx implant, is a helical, barbed, absorbable device designed to close the fistula tract within the sphincter muscle, addressing key shortcomings of current surgical options like high recurrence and incontinence risk. The company is led by a seasoned medtech executive team with a strong track record of innovation and exits. Signum is positioned to address a significant unmet clinical need in a sizable procedural market, primarily in the United States and Europe.

Therapeutic Areas